Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 121 to 124 of 124 entries
Sorted by: Best Match Show Resources per page
Serum neuron-specific enolase: a new tool for seizure risk monitoring after status epilepticus.

European journal of neurology

Hanin A, Demeret S, Denis JA, Nguyen-Michel VH, Rohaut B, Marois C, Imbert-Bismut F, Bonnefont-Rousselot D, Levy P, Navarro V, Lambrecq V.
PMID: 34687105
Eur J Neurol. 2021 Oct 22; doi: 10.1111/ene.15154. Epub 2021 Oct 22.

BACKGROUND AND PURPOSE: There is a need for accurate biomarkers to monitor electroencephalography (EEG) activity and assess seizure risk in patients with acute brain injury. Seizure recurrence may lead to cellular alterations and subsequent neurological sequelae. Whether neuron-specific enolase...

Cite
Hanin A, Demeret S, Denis JA, et al. Serum neuron-specific enolase: a new tool for seizure risk monitoring after status epilepticus. Eur J Neurol. 2021;doi: 10.1111/ene.15154.
Hanin, A., Demeret, S., Denis, J. A., Nguyen-Michel, V. H., Rohaut, B., Marois, C., Imbert-Bismut, F., Bonnefont-Rousselot, D., Levy, P., Navarro, V., & Lambrecq, V. (2021). Serum neuron-specific enolase: a new tool for seizure risk monitoring after status epilepticus. European journal of neurology, . https://doi.org/10.1111/ene.15154
Hanin, Aurélie, et al. "Serum neuron-specific enolase: a new tool for seizure risk monitoring after status epilepticus." European journal of neurology vol. (2021). doi: https://doi.org/10.1111/ene.15154
Hanin A, Demeret S, Denis JA, Nguyen-Michel VH, Rohaut B, Marois C, Imbert-Bismut F, Bonnefont-Rousselot D, Levy P, Navarro V, Lambrecq V. Serum neuron-specific enolase: a new tool for seizure risk monitoring after status epilepticus. Eur J Neurol. 2021 Oct 22; doi: 10.1111/ene.15154. Epub 2021 Oct 22. PMID: 34687105.
Copy Download .nbib Format: NLM
[Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores].

Bulletin du cancer

Perrier A, Hainaut P, Lamy PJ, Guenoun A, Nguyen DP, Guerber F, Troalen F, Denis JA, Boissan M.
PMID: 35012767
Bull Cancer. 2022 Jan 07; doi: 10.1016/j.bulcan.2021.11.010. Epub 2022 Jan 07.

In oncology, the identification of targets that correlate with a type of cancer has led to a profound change in the notion of "tumor markers". Technological advances, in particular the development of high-throughput sequencing, have led to the emergence...

Cite
Perrier A, Hainaut P, Lamy PJ, et al. Utilisation clinique et évolution des biomarqueurs circulants à l’ère de l’oncologie personnalisée : des marqueurs protéiques aux scores clinicobiologiques. [Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores]. Bull Cancer. 2022;doi: 10.1016/j.bulcan.2021.11.010.
Perrier, A., Hainaut, P., Lamy, P. J., Guenoun, A., Nguyen, D. P., Guerber, F., Troalen, F., Denis, J. A., & Boissan, M. (2022). Utilisation clinique et évolution des biomarqueurs circulants à l’ère de l’oncologie personnalisée : des marqueurs protéiques aux scores clinicobiologiques. [Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores]. Bulletin du cancer, . https://doi.org/10.1016/j.bulcan.2021.11.010
Perrier, Alexandre, et al. "Utilisation clinique et évolution des biomarqueurs circulants à l’ère de l’oncologie personnalisée : des marqueurs protéiques aux scores clinicobiologiques." [Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores]. Bulletin du cancer vol. (2022). doi: https://doi.org/10.1016/j.bulcan.2021.11.010
Perrier A, Hainaut P, Lamy PJ, Guenoun A, Nguyen DP, Guerber F, Troalen F, Denis JA, Boissan M. Utilisation clinique et évolution des biomarqueurs circulants à l’ère de l’oncologie personnalisée : des marqueurs protéiques aux scores clinicobiologiques. [Clinical use and evolution of circulating biomarkers in the era of personalized oncology: From protein markers to bioclinical scores]. Bull Cancer. 2022 Jan 07; doi: 10.1016/j.bulcan.2021.11.010. Epub 2022 Jan 07. French. PMID: 35012767.
Copy Download .nbib Format: NLM
Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth.

JAMA psychiatry

King CA, Brent D, Grupp-Phelan J, Casper TC, Dean JM, Chernick LS, Fein JA, Mahabee-Gittens EM, Patel SJ, Mistry RD, Duffy S, Melzer-Lange M, Rogers A, Cohen DM, Keller A, Shenoi R, Hickey RW, Rea M, Cwik M, Page K, McGuire TC, Wang J, Gibbons R.
PMID: 33533908
JAMA Psychiatry. 2021 May 01;78(5):540-549. doi: 10.1001/jamapsychiatry.2020.4576.

IMPORTANCE: The rate of suicide among adolescents is rising in the US, yet many adolescents at risk are unidentified and receive no mental health services.OBJECTIVE: To develop and independently validate a novel computerized adaptive screen for suicidal youth (CASSY)...

Cite
King CA, Brent D, Grupp-Phelan J, et al. Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth. JAMA Psychiatry. 2021;78(5):540-549doi: 10.1001/jamapsychiatry.2020.4576.
King, C. A., Brent, D., Grupp-Phelan, J., Casper, T. C., Dean, J. M., Chernick, L. S., Fein, J. A., Mahabee-Gittens, E. M., Patel, S. J., Mistry, R. D., Duffy, S., Melzer-Lange, M., Rogers, A., Cohen, D. M., Keller, A., Shenoi, R., Hickey, R. W., Rea, M., Cwik, M., Page, K., McGuire, T. C., Wang, J., Gibbons, R. (2021). Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth. JAMA psychiatry, 78(5), 540-549. https://doi.org/10.1001/jamapsychiatry.2020.4576
King, Cheryl A, et al. "Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth." JAMA psychiatry vol. 78,5 (2021): 540-549. doi: https://doi.org/10.1001/jamapsychiatry.2020.4576
King CA, Brent D, Grupp-Phelan J, Casper TC, Dean JM, Chernick LS, Fein JA, Mahabee-Gittens EM, Patel SJ, Mistry RD, Duffy S, Melzer-Lange M, Rogers A, Cohen DM, Keller A, Shenoi R, Hickey RW, Rea M, Cwik M, Page K, McGuire TC, Wang J, Gibbons R. Prospective Development and Validation of the Computerized Adaptive Screen for Suicidal Youth. JAMA Psychiatry. 2021 May 01;78(5):540-549. doi: 10.1001/jamapsychiatry.2020.4576. PMID: 33533908; PMCID: PMC7859874.
Copy Download .nbib Format: NLM
A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans.

Colon-Otero G, Albertie M, Lesperance M, Weis JA, Coles A, Smith N, Mills L, Woodward T, Aspitia AM, Vishnu P, Willis F, Isley A, Fonseca R, Vachon C, Rajkumar SV.
UIID-AD: 2552
2012;27:294-8. doi: 10.1007/s13187-011-0288-x.

African Americans are underrepresented in cancer research. We evaluate whether collaboration with African American churches can improve cancer awareness and increase participation in translational research protocols among African Americans. From February to April 2010, the Mayo Clinic partnered with...

Cite
Colon-Otero G, Albertie M, Lesperance M, et al. A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans. 2012;27:294-8doi: 10.1007/s13187-011-0288-x.
Colon-Otero, G., Albertie, M., Lesperance, M., Weis, J. A., Coles, A., Smith, N., Mills, L., Woodward, T., Aspitia, A. M., Vishnu, P., Willis, F., Isley, A., Fonseca, R., Vachon, C., & Rajkumar, S. V. (2012). A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans. 27294-8. https://doi.org/10.1007/s13187-011-0288-x
Colon-Otero, G, et al. "A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans." vol. 27 (2012): 294-8. doi: https://doi.org/10.1007/s13187-011-0288-x
Colon-Otero G, Albertie M, Lesperance M, Weis JA, Coles A, Smith N, Mills L, Woodward T, Aspitia AM, Vishnu P, Willis F, Isley A, Fonseca R, Vachon C, Rajkumar SV. A pilot program in collaboration with African American churches successfully increases awareness of the importance of cancer research and participation in cancer translational research studies among African Americans. 2012;27:294-8. doi: 10.1007/s13187-011-0288-x. UIID-AD: 2552.
Copy Download .nbib Format: NLM
Showing 121 to 124 of 124 entries